- HOME
- About
Corporate Profile
| Name | RACTHERA Co., Ltd. |
|---|---|
| Establishment | November 15, 2024 |
| Representative | Atsushi Ikeda, Representative Director, President and CEO |
| Employees | 114(as of March 31, 2026) |
| Capitalization | 100 million yen (as of March 31, 2026) |
| Head Office | Tokyo Nihombashi Tower, 2-7-1, Nihonbashi, Chuo-ku, Tokyo 103-6012, Japan |
| Main Number | +81-3-5205-3720 |
| Shareholder | Sumitomo Chemical Co., Ltd. 66.6% Sumitomo Pharma Co., Ltd. 33.4% |
| Business | Research, development, manufacturing, sales and import/export of regenerative medical products and other |
Access
Tokyo Head Office
Tokyo Nihombashi Tower, 2-7-1, Nihonbashi, Chuo-ku, Tokyo 103-6012, Japan Reception: 7th Floor
Access
- From Nihombashi Station
Direct access from the Station on Tokyo Metro Ginza Line/Tozai Line or Toei Asakusa Line. - From Mitsukosimae Station
3 minutes on foot from the Exit B6 on Tokyo Metro Ginza Line/Hanzomon Line. - From Tokyo Station
6 minutes on foot from the Yaesu North Exit on JR Line or Tokyo Metro Marunouchi Line.
Kobe Research Center
1-5-2 Minatojima Minamimachi, Chuo-ku. Kobe, Hyogo 650-0047, Japan
Access
Direct access from Iryo Center(Shimin Byoin Mea) Station on Kobe New Transit Port Liner line.
Central Research Laboratories
33-94, Enoki-cho, Suita, Osaka 564-0053, Japan
Access
7 minutes on foot from the subway Midosuji Line Esaka Station (South Exit)